학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 149건 | 목록 1~20
Academic Journal
Bournet, BarbaraCanivet, CindyBuscail, LouisCarrere, NicolasMuscari, FabriceSuc, BertrandGuimbaud, RosineCouteau, CorinneDeslandres, MarionRivera, PascaleLaurenty, Anne-PascaleFares, NadimBarange, KarlSelves, JanickGomez-Brouchet, AnneNapoleon, BertrandPujol, BertrandFumex, FabienDesrame, JeromeLefort, ChristineLepilliez, VincentGincul, RodicaArtru, PascalClavel, LeaLemaistre, Anne-IsabellePalazzo, LaurentCros, JeromeTubiana, SarahFlori, NicolasSenesse, PierreColombo, Pierre-EmmanuelSamailScalzi, EmmanuellePortales, FabienneGourgou, SophieGa, Claire HonfoPlassot, CarineFraisse, JulienBibeau, Fred ericYchou, MarcGuibert, PierreFouchardiere, Christelle de laSarabi, MatthieuPeyrat, PatriceTabone-Eglinger, SeverineRenard, CarolinePiessen, GuillaumeTruant, StephanieSaudemont, AlainMillet, GuillaumeRenaud, FlorenceLeteurtre, EmmanuelleGele, PatrickAssenat, EricFabre, Jean-MichelSouche, Francois-RegisDupuy, MarieGorce-Dupuy, Anne-MarieRamos, JeanneSeitz, Jean-FrancoisHardwigsen, JeanNorguet-Monnereau, EmmanuelleGrandval, PhilippeDuluc, MurielFigarella-Branger, DominiqueVendrely, VeroniqueSubtil, ClementTerrebonne, EricBlanc, Jean-FredericBuscail, EtienneMerlio, Jean-PhilippeBancel, Dominique FargesGornet, Jean-MarcGeromin, DanielaVanbiervliet, GeoffroyFrin, Anne-ClaireOuvrier, DelphineSaintPaul, Marie-ChristineBerthelemy, PhilippeFouad, ChelbabiGarcia, StephaneLesavre, NathalieGasmi, MohamedBarthet, MarcCottet, VanessaDelpierre, CyrilleAlouani, E.Canivet, C.Bournet, B.Buscail, L.Selves, J.Napoleon, B.Palazzo, L.Flori, N.Guibert, P.Brunac, A.-C.Maulat, C.Muscari, F.Mokrane, F.-Z.Gourgou, S.Roca, L.Guimbaud, R.Fares, N.
In ESMO Gastrointestinal Oncology June 2025 8
Academic Journal
Vitte AL; Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, 38000 Grenoble, France.; Chuffart F; Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, 38000 Grenoble, France.; Jacquet E; Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, 38000 Grenoble, France.; Medical Oncology Unit, Cancer and Blood Diseases Department, CHU Grenoble Alpes, CS 10217 - 38043 Grenoble cedex 09, France.; Nika E; Department of Pathology, CHU Grenoble Alpes, CS 10217 - 38043 Grenoble cedex 09, France.; Mousseau M; Medical Oncology Unit, Cancer and Blood Diseases Department, CHU Grenoble Alpes, CS 10217 - 38043 Grenoble cedex 09, France.; Jung I; Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, 38000 Grenoble, France.; Tabone-Eglinger S; Plateforme de Gestion des Echantillons Biologiques, Centre Léon Bérard, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.; Bachelot T; Department of Oncology, Centre Léon Bérard, Cancer Research Center of Lyon, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.; Rousseaux S; Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, 38000 Grenoble, France.; Khochbin S; Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, 38000 Grenoble, France.; Bourova-Flin E; Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences, 38000 Grenoble, France.
Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: MEDLINE
Academic Journal
Paternot S; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Raspé E; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Meiller C; Université de Paris, Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Functional Genomics of Solid Tumors, France.; Tarabichi M; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Assié JB; Université de Paris, Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Functional Genomics of Solid Tumors, France.; CEpiA (Clinical Epidemiology and Ageing), EA 7376-IMRB, University Paris-Est Créteil, France.; GRC OncoThoParisEst, Service de Pneumologie, CHI Créteil, UPEC, Créteil, France.; Libert F; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; BRIGHTCore, ULB, Brussels, Belgium.; Remmelink M; Department of Pathology, Erasme Hospital, Université Libre de Bruxelles, Belgium.; Bisteau X; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.; Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Blum Y; Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, Paris, France.; Le Stang N; MESOBANK, Department of Biopathology, Centre Léon Bérard, Lyon, France.; Tabone-Eglinger S; MESOBANK, Department of Biopathology, Centre Léon Bérard, Lyon, France.; Galateau-Sallé F; MESOBANK, Department of Biopathology, Centre Léon Bérard, Lyon, France.; Cancer Research Center INSERM U1052-CNRS 5286R, Lyon, France.; Blanquart C; Inserm, CNRS, Université d'Angers, CRCI2NA, Nantes Université, Nantes, France.; Van Meerbeeck JP; Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium.; Berghmans T; Clinic of Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Jean D; Université de Paris, Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Functional Genomics of Solid Tumors, France.; Roger PP; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, Belgium.; ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles, Belgium.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Collet L; Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium.; Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium.; Department of Medical Oncology, Centre Leon Berard, Lyon, France.; Telouk P; Ecole Normale Supérieure de Lyon and CNRS UMR 5276, Lyon, France.; Albarede F; Ecole Normale Supérieure de Lyon and CNRS UMR 5276, Lyon, France.; Girodet M; Department of Human and Social Sciences, Centre Léon-Bérard, Lyon, France.; Maqua C; Medical Practice Evaluation and Networks Team, Centre Léon Bérard, Lyon, France.; Rogasik M; Medical Practice Evaluation and Networks Team, Centre Léon Bérard, Lyon, France.; Ducimetière F; Medical Practice Evaluation and Networks Team, Centre Léon Bérard, Lyon, France.; Tabone-Eglinger S; Biological Resources Center, Department of Biopathology, Centre Léon Bérard, Lyon, France.; Brahmi M; Department of Medical Oncology, Centre Leon Berard, Lyon, France.; Dufresne A; Department of Medical Oncology, Centre Leon Berard, Lyon, France.; Thomas DM; Garvan Institute of Medical Research, Sydney, 2010, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, 2010, Australia.; Ballinger ML; Garvan Institute of Medical Research, Sydney, 2010, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, 2010, Australia.; Blay JY; Department of Medical Oncology, Centre Leon Berard, Lyon, France.; Ray-Coquard I; Department of Medical Oncology, Centre Leon Berard, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.
Publisher: Springer Country of Publication: United States NLM ID: 101274889 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-3890 (Electronic) Linking ISSN: 15733882 NLM ISO Abbreviation: Metabolomics Subsets: MEDLINE
Academic Journal
Vogrig A; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Clinical Neurology, Santa Maria della Misericordia University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.; Department of Medicine (DAME), University of Udine, Udine, Italy.; Pegat A; Service ENMG et Pathologies Neuromusculaires, Hôpital Neurologique P. Wertheimer, Hospices Civils de Lyon, Bron, France.; Pathophysiology and Genetics of Neuron and Muscle, CNRS UMR 5261, INSERM U1315, INMG, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, Lyon, France.; Villagrán-García M; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Wucher V; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Attignon V; Cancer Genomic Platform, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Sohier E; Gilles Thomas Bioinformatics Platform, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Fondation Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.; Brevet M; Department of Pathology, Lyon Est Hospital, Hospices Civils de Lyon, Bron, France.; Rogemond V; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Pinto AL; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Muñiz-Castrillo S; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Stanford Center for Sleep Sciences and Medicine, Stanford University, Palo Alto, CA, USA.; Peter E; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Robert M; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Picard G; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Hopes L; Department of Neurology, CHRU Nancy, Nancy, France.; Psimaras D; Neurology 2 Department Mazarin, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.; Sorbonne Université, INSERM, CNRS, Paris Brain Institute, Institut du Cerveau et de la Moelle Épinière, ICM, Paris, France.; Terra A; Centre de Ressources Biologiques Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Perrin C; Centre de Ressources Biologiques Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Cogne D; Plateforme de Gestion des Echantillons Biologique, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Tabone-Eglinger S; Plateforme de Gestion des Echantillons Biologique, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Martinez S; Plateforme de Gestion des Echantillons Biologique, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Jury D; Plateforme de Gestion des Echantillons Biologique, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Valantin J; Plateforme Anatomopathologie Recherche, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS Centre Léon Bérard, Lyon, France.; Gadot N; Plateforme Anatomopathologie Recherche, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS Centre Léon Bérard, Lyon, France.; Auclair-Perrossier J; Cancer Genomic Platform, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Viari A; Gilles Thomas Bioinformatics Platform, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Dubois B; Cancer Immune Surveillance and Therapeutic Targeting Team, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS, Centre Léon Bérard, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory, Cancer Research Center of Lyon, Lyon, France.; Desestret V; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.; Honnorat J; French Reference Center of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Mechanisms in integrated life sciences Institute, (MeLiS), INSERM U1314, CNRS UMR 5284, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7707449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8249 (Electronic) Linking ISSN: 03645134 NLM ISO Abbreviation: Ann Neurol Subsets: MEDLINE
Academic Journal
Mourksi NE; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Université de Lyon, Lyon, France.; Institut Convergence PLAsCAN, Lyon, France.; DevWeCan Labex Laboratory, Lyon, France.; Dalban C; Clinical Research Department, Centre Léon Bérard, Lyon, France.; Colombe-Vermorel A; Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.; Odeyer L; Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.; Simioni V; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Université de Lyon, Lyon, France.; Institut Convergence PLAsCAN, Lyon, France.; DevWeCan Labex Laboratory, Lyon, France.; Frenel JS; Medical Oncology Department, Institut Cancérologie de l'Ouest, and GINEGEPS, St Herblain, France.; Fabbro M; Department of Surgical Oncology, Institut du Cancer de Montpellier, University of Montpellier, Montpellier, France.; Bazan F; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.; Abadie-Lacourtoisie S; Institut de Cancérologie de l'Ouest, Angers, France.; Coquan E; Department of Clinical Research, Department of Medical Oncology, Comprehensive Cancer Centre François Baclesse, Caen, France.; Martinez S; Biological Resource Center, Centre Léon Bérard, Lyon, France.; Garin G; Clinical Research Department, Centre Léon Bérard, Lyon, France.; Tabone-Eglinger S; Biological Resource Center, Centre Léon Bérard, Lyon, France.; Treilleux I; Biopathology Department, Centre Léon Bérard, GINECO, Lyon, France.; Chabaud S; Clinical Research Department, Centre Léon Bérard, Lyon, France.; Pérol D; Clinical Research Department, Centre Léon Bérard, Lyon, France.; Ray-Coquard I; Medical Oncology Department, Centre Léon Bérard and University Claude Bernard Lyon 1, GINECO, Lyon, France.; Heudel PE; Medical Oncology Department, Centre Léon Bérard and University Claude Bernard Lyon 1, GINECO, Lyon, France.; Diaz JJ; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Université de Lyon, Lyon, France.; Institut Convergence PLAsCAN, Lyon, France.; DevWeCan Labex Laboratory, Lyon, France.; Marcel V; Centre de Recherche en Cancérologie de Lyon, Inserm U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Centre Léon Bérard, Université de Lyon, Lyon, France.; Institut Convergence PLAsCAN, Lyon, France.; DevWeCan Labex Laboratory, Lyon, France.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Le Saux O; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France.; Ardin M; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Berthet J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Barrin S; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Bourhis M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Cinier J; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lounici Y; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Treilleux I; Department of Anatomopathology, Centre Léon Bérard, 69008, Lyon, France.; Just PA; Department of Anatomopathology, AP-HM, Marseille, France.; Bataillon G; Department of Anatomopathology, University hospital of Toulouse, Toulouse, France.; Savoye AM; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Institut Jean Godinot, Reims, France.; Mouret-Reynier MA; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.; Coquan E; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France.; Department of Medical Oncology, Centre François Baclesse, Caen, France.; Derbel O; Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon, France.; Jeay L; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France.; Bouizaguen S; Keen Eye Technologies-Paris, France, now Tribun Health, Paris, France.; Labidi-Galy I; Department of Oncology, Hôpitaux universitaires de Genève, Faculty of Medecine, Center of Translational Research in Onco-Hematology, Swiss Cancer Center Leman, Geneva, Switzerland.; Tabone-Eglinger S; Human Biological Resources, Centre Léon Bérard, 69008, Lyon, France.; Ferrari A; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France.; Thomas E; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, CEDEX 08, F-69373, Lyon, France.; Ménétrier-Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Tartour E; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Galy-Fauroux I; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie, PSL Research University, 75005, Paris, France.; Terme M; Université Paris Cité, Inserm, PARCC, F-75015, Paris, France.; Caux C; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France.; Dubois B; 'Cancer Immune Surveillance and Therapeutic Targeting' Laboratory, Cancer Research Center of Lyon, INSERM 1052-CNRS 5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Lyon Immunotherapy for Cancer Laboratory (LICL), Cancer Research Center of Lyon, Centre Léon Bérard, 69008, Lyon, France. bertrand.dubois@lyon.unicancer.fr.; Ray-Coquard I; Lyon University, Université Claude Bernard Lyon 1, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.; National Investigators Group for Ovarian and Breast Cancer Studies, Paris, France. isabelle.ray-coquard@lyon.unicancer.fr.; Department of Medical Oncology, Centre Léon Bérard, 69008, Lyon, France. isabelle.ray-coquard@lyon.unicancer.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Dufresne A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Attignon V; Platform of Cancer Genomics, Centre Léon Bérard, Lyon, France.; Ferrari A; Platform of Bioinformatics Gilles-Thomas, Centre Léon Bérard, Lyon, France.; Tonon L; Platform of Bioinformatics Gilles-Thomas, Centre Léon Bérard, Lyon, France.; Boyault S; Platform of Cancer Genomics, Centre Léon Bérard, Lyon, France.; Tabone-Eglinger S; Biobank, Centre Léon Bérard, Lyon, France.; Cassier P; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Trédan O; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Corradini N; Department of Pediatric Oncology, Institute of Pediatric Hematology and Oncology, Centre Leon Bérard, Lyon, France.; Vinceneux A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Swalduz A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Viari A; Platform of Bioinformatics Gilles-Thomas, Centre Léon Bérard, Lyon, France.; Chabaud S; Department of Clinical Research, Centre Léon Bérard, Lyon, France.; Pérol D; Department of Clinical Research, Centre Léon Bérard, Lyon, France.; Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Univ Lyon, Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.; Saintigny P; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Univ Lyon, Claude Bernard Lyon 1 University, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Tabone-Eglinger, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어